Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Yonsei University

South Korea · Asia-Pacific · Platinum

★ Sector Awards 2026. Finalist: the Batteries and Energy Storage Award (with Hyundai Motors; Jaejin Lim and Youngjoon Roh).

#47World rank of 1,038
79.5ICI scoreout of 100
#3National rank, of 28 in South Korea
#13Regional rank, of 343 in Asia-Pacific
2,659.5Verified industry works, 2021 to 2025
668Company groups worked with (256 on two or more works)

Yonsei University is ranked #47 of 1,038, with Platinum standing. Its strongest pillar is durability (97): 80 of its company groups are sustained partners (five or more joint works in three or more of the five years). It is held back most by breadth (38): partners concentrated in a few research fields.

Research Collaboration Index 2026: #204 of 1,195, Gold standing · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
84

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 2,659.5 verified works against about 1,872 expected for its fields (1.42 times the expected rate).

Durability20% of the score
97

How much of its industry work sits in sustained partnerships with the same company group. 80 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
92

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 256 company groups on two or more joint works; 80 sustained partnerships.

Breadth20% of the score
38

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (79.5) is the weighted average of the four percentiles. Rank 47 of 1,038 overall; 3 of 28 in South Korea; 13 of 343 in Asia-Pacific. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

6.0%of its 44,085 research works in 2021 to 2025 were co-authored with a verified company
1.42Industry co-authorship rate: 1.42 times what its mix of research fields would predict (2,659.5 verified works; about 1,872 expected)
80sustained partnerships: the same company group on five or more joint works in three or more of the five years

In South Korea

3 of 28 ranked universities in South Korea

  1. #1 Seoul National University world #18, score 84.6
  2. #2 Sungkyunkwan University world #35, score 80.9
  3. #3 Yonsei University world #47, score 79.5
  4. #4 Korea Advanced Institute of Science and Technology world #201, score 69.0
  5. #5 University of Ulsan world #209, score 68.3

All ranked universities →   Asia-Pacific: 13 of 343 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#28 of 638Pharmaceuticals and Therapeutics792.5 verified works in the sector
#48 of 323Medical Technology and Digital Health102 verified works in the sector
#50 of 292Artificial Intelligence84 verified works in the sector
Pharmaceuticals and Therapeutics
792.5#28 of 638
Advanced Materials and Nanotechnology
134.5#106 of 481
Medical Technology and Digital Health
102#48 of 323
Artificial Intelligence
84#50 of 292
Clean Energy Transition
62#132 of 295
Next-Generation Communications
60#59 of 188
Biotechnology and Advanced Therapies
54#66 of 220
Semiconductors and Microelectronics
52.5#37 of 109
Batteries and Energy Storage
40.5#58 of 126
Climate, Environment and Sustainability
40.5#168 of 373
Advanced Manufacturing and Industry 4.0
35.5#128 of 201
Software, Cloud and Data
35.5#84 of 167
Built Environment and Infrastructure
35#109 of 215
Chemicals, Process and Resources
22.5#230 of 237
Automotive and Mobility
9under 20 works
Aerospace and Aviation
7.5under 20 works
Quantum Technologies
4under 20 works
Robotics and Autonomous Systems
4ranking withheld (under 10 eligible)
Space and Satellite Technology
4under 20 works
Cybersecurity and Digital Trust
3.5under 20 works
Agriculture and Food Technology
1.5under 20 works
Not in any of the 21 sectors
1,068.5counted in the overall index

1,591 of its 2,659.5 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Yonsei University co-authored verified work with 668 company groups, consortium papers aside: 256 of them on two or more works, and 80 as sustained partners.

The largest 12 of its 668 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
SamsungSouth KoreaEngineering4195 of 5
AstraZenecaUnited KingdomMedicine1495 of 5
Merck & Co. (MSD)United StatesMedicine1375 of 5
Johnson & JohnsonUnited StatesMedicine108.55 of 5
Hyundai MotorsSouth KoreaEngineering85.55 of 5
Pohang Iron and SteelSouth KoreaEngineering56.55 of 5
SK GroupSouth KoreaEngineering555 of 5
Hanmi PharmaceuticalSouth KoreaMedicine475 of 5
RocheSwitzerlandMedicine435 of 5
PfizerUnited StatesMedicine425 of 5
LGSouth KoreaEngineering38.55 of 5
EisaiJapanMedicine38.55 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Its most-cited verified works with 30 or fewer authors, leaving out guidelines and consensus statements. Citation counts are those of the open scholarly record at harvest. Each title links to the work.

Over time

Verified industry works by year

466.52021
458.52022
5212023
571.52024
6422025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

20 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT07380438 A Clinical Study to Evaluate the Efficacy of a Nutritional Supplement to Improve Carotenoid Content as Measured by a Non-invasive Hyperspectral Absorption Device with Pharmanex, 2025
  • NCT06922890 First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury with Stand Up Therapeutics INC., 2025
  • NCT06890572 Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients with LG Electronics Inc., 2025
  • NCT07513415 A Comparative Study on the Safety and Efficacy of the Intra-Articular Injectable Filler ALLOHEAL in Patients With Knee Osteoarthritis with Endovision Co., Ltd., 2025
  • NCT06502743 First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer with Onconic Therapeutics Inc., 2024
  • NCT06023862 A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) with GlaxoSmithKline, 2024

Funded partnerships (reported, not scored)

Publicly funded research projects with companies

European Union: 2 Horizon projects with company partners

Horizon 2020 and Horizon Europe projects starting 2021-2025 in which this university and at least one company take part (7 distinct companies). Company partners include: Alstom Engineering and Services Lim, Centro de Estudios de Materiales y Control de Obra SA, Martel GmbH, Opennebula Systems SL, Software for Critical Systems SL, V-tron BV.

  • NexusForum.EU Consolidating Research and Policy along the Cognitive Computing Continuum 2024, 2 companies
  • EVOLVE Electric Vehicles Point Location Optimisation via Vehicular Communications 2023, 5 companies

Shown for context from the public grant registries; they do not enter the score in Edition 1. Comparable open registries of company partners exist for the European Union and the United Kingdom but not yet for most other research systems, and in some countries national research organisations take part on behalf of university laboratories, so these counts are not comparable between countries.

Evidence checked

3,869 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 1,517 of 5,386 candidate links were set aside.

Why links were set aside
  • 831 company name not written in the author's affiliation
  • 255 ordinary-word name without a company suffix
  • 244 part of a university or public institute's own unit
  • 55 a place or common word that failed its stricter rule
  • 22 part of a street or district address
  • 11 excluded after hand audit: Matched almost only from the Flatiron Institute, a non-profit research institute
  • 99 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

For your communications

Badges you can use

Platinum standing badgeSector Awards finalist badge

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where Yonsei University's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Yonsei University ranks #204 of 1,195, with Gold standing. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.